Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioject Medical Technologies Inc.
Bioject Announces Long-Term Agreement with Merial Limited
July 16th, 2008
Bioject Medical Technologies Inc. (Nasdaq:BJCT) ("Bioject"), a leading developer of needle-free injection therapy (NFIT) systems, announced that it has signed a new long-term exclusive license, development and supply agreement with Merial Limited ("Merial"), a world leading animal health company, for a next generation companion animal device which allows for the delivery of injectables. This new device will allow Merial to deliver certain of their companion animal vaccines with a single device. Details of the financial agreement with Bioject were not disclosed, but terms of the agreement include an upfront license payment, development milestone payments, a provision for capital equipment...
Source: Vaccine Weekly (2008-07-16)
|
